TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 304 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $720,341 | +65.2% | 43,710 | +30.1% | 0.00% | – |
| Q3 2022 | $436,000 | -31.3% | 33,601 | -25.8% | 0.00% | – |
| Q2 2022 | $635,000 | -11.4% | 45,259 | -9.6% | 0.00% | – |
| Q1 2022 | $717,000 | -35.1% | 50,065 | -22.0% | 0.00% | – |
| Q3 2019 | $1,105,000 | -5.6% | 64,209 | -2.9% | 0.00% | – |
| Q2 2019 | $1,171,000 | -17.4% | 66,143 | -4.9% | 0.00% | – |
| Q1 2019 | $1,417,000 | – | 69,557 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
| Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
| Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
| XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
| Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
| Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
| Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
| HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |